Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Models, Genetic | 38 | 2023 | 3493 | 5.420 |
Why?
|
Genetic Association Studies | 27 | 2023 | 2694 | 4.480 |
Why?
|
Genome-Wide Association Study | 56 | 2024 | 12178 | 4.030 |
Why?
|
Polymorphism, Single Nucleotide | 66 | 2024 | 15500 | 2.620 |
Why?
|
Quantitative Trait Loci | 12 | 2023 | 2016 | 1.930 |
Why?
|
Software | 14 | 2023 | 4423 | 1.900 |
Why?
|
Data Interpretation, Statistical | 22 | 2019 | 2716 | 1.860 |
Why?
|
Genetic Variation | 19 | 2023 | 6539 | 1.800 |
Why?
|
Biometry | 14 | 2011 | 558 | 1.630 |
Why?
|
Models, Statistical | 25 | 2020 | 5113 | 1.610 |
Why?
|
Sequence Analysis, DNA | 11 | 2022 | 4791 | 1.510 |
Why?
|
Genome, Human | 11 | 2023 | 4419 | 1.500 |
Why?
|
Likelihood Functions | 11 | 2018 | 1004 | 1.460 |
Why?
|
Phenotype | 30 | 2023 | 16301 | 1.440 |
Why?
|
Algorithms | 21 | 2022 | 13872 | 1.380 |
Why?
|
Lung Neoplasms | 35 | 2024 | 12985 | 1.350 |
Why?
|
DNA Methylation | 25 | 2021 | 4269 | 1.300 |
Why?
|
Genome | 7 | 2022 | 1794 | 1.300 |
Why?
|
Computer Simulation | 37 | 2023 | 6237 | 1.300 |
Why?
|
Linear Models | 23 | 2020 | 5948 | 1.190 |
Why?
|
Epigenomics | 5 | 2020 | 877 | 1.110 |
Why?
|
Genetic Markers | 6 | 2016 | 2630 | 1.100 |
Why?
|
Welding | 9 | 2017 | 89 | 1.090 |
Why?
|
Genetic Predisposition to Disease | 35 | 2024 | 17384 | 1.040 |
Why?
|
Nasopharyngeal Neoplasms | 2 | 2024 | 284 | 0.920 |
Why?
|
Genetics, Population | 7 | 2019 | 931 | 0.850 |
Why?
|
Computational Biology | 8 | 2020 | 3506 | 0.810 |
Why?
|
Lipids | 5 | 2023 | 3307 | 0.790 |
Why?
|
Epstein-Barr Virus Infections | 2 | 2024 | 566 | 0.730 |
Why?
|
Case-Control Studies | 30 | 2024 | 21694 | 0.720 |
Why?
|
Smoking | 19 | 2021 | 8960 | 0.710 |
Why?
|
CpG Islands | 9 | 2020 | 1163 | 0.700 |
Why?
|
Principal Component Analysis | 6 | 2016 | 937 | 0.670 |
Why?
|
Occupational Exposure | 12 | 2017 | 1791 | 0.670 |
Why?
|
Biological Specimen Banks | 3 | 2022 | 692 | 0.660 |
Why?
|
Humans | 219 | 2024 | 739398 | 0.640 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 17 | 2023 | 5154 | 0.620 |
Why?
|
Gene Expression Profiling | 11 | 2020 | 9387 | 0.600 |
Why?
|
Pedigree | 4 | 2021 | 4640 | 0.600 |
Why?
|
Quantitative Trait, Heritable | 3 | 2016 | 545 | 0.580 |
Why?
|
Particulate Matter | 12 | 2021 | 2511 | 0.570 |
Why?
|
Sample Size | 6 | 2021 | 845 | 0.560 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2022 | 3571 | 0.550 |
Why?
|
Epigenesis, Genetic | 15 | 2020 | 3614 | 0.550 |
Why?
|
Family | 4 | 2017 | 3141 | 0.540 |
Why?
|
Arsenic | 4 | 2014 | 325 | 0.530 |
Why?
|
Molecular Sequence Annotation | 3 | 2023 | 524 | 0.510 |
Why?
|
Rare Diseases | 3 | 2018 | 553 | 0.510 |
Why?
|
Survival Analysis | 7 | 2018 | 10247 | 0.510 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 744 | 0.510 |
Why?
|
Regression Analysis | 10 | 2022 | 6452 | 0.500 |
Why?
|
Neuroendocrine Tumors | 6 | 2017 | 593 | 0.490 |
Why?
|
Statistics as Topic | 3 | 2018 | 2373 | 0.480 |
Why?
|
Longitudinal Studies | 20 | 2020 | 13880 | 0.480 |
Why?
|
Oxyhemoglobins | 3 | 2019 | 216 | 0.460 |
Why?
|
Disease | 1 | 2019 | 683 | 0.450 |
Why?
|
Logistic Models | 14 | 2018 | 13402 | 0.450 |
Why?
|
Arsenic Poisoning | 2 | 2015 | 55 | 0.440 |
Why?
|
Causality | 4 | 2021 | 1262 | 0.440 |
Why?
|
Population | 1 | 2013 | 142 | 0.430 |
Why?
|
Environmental Exposure | 7 | 2021 | 4220 | 0.430 |
Why?
|
Mandibulofacial Dysostosis | 1 | 2011 | 34 | 0.420 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 4 | 2022 | 314 | 0.420 |
Why?
|
Genetic Pleiotropy | 1 | 2013 | 182 | 0.410 |
Why?
|
Craniofacial Dysostosis | 1 | 2011 | 73 | 0.410 |
Why?
|
Micrognathism | 1 | 2011 | 54 | 0.410 |
Why?
|
Hypersensitivity, Immediate | 3 | 2019 | 330 | 0.410 |
Why?
|
Linkage Disequilibrium | 5 | 2023 | 1992 | 0.400 |
Why?
|
Proportional Hazards Models | 10 | 2019 | 12328 | 0.400 |
Why?
|
Bayes Theorem | 7 | 2024 | 2303 | 0.400 |
Why?
|
Asthma | 11 | 2019 | 5950 | 0.390 |
Why?
|
Metals | 4 | 2016 | 718 | 0.390 |
Why?
|
Population Groups | 1 | 2012 | 207 | 0.390 |
Why?
|
Sleep Apnea, Obstructive | 6 | 2022 | 1806 | 0.380 |
Why?
|
Limb Deformities, Congenital | 1 | 2011 | 136 | 0.380 |
Why?
|
Sequence Analysis | 1 | 2011 | 257 | 0.370 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2012 | 374 | 0.370 |
Why?
|
Poisson Distribution | 2 | 2011 | 516 | 0.370 |
Why?
|
Coronavirus Infections | 4 | 2020 | 3143 | 0.370 |
Why?
|
Pneumonia, Viral | 4 | 2020 | 3248 | 0.360 |
Why?
|
Genotype | 19 | 2023 | 12951 | 0.360 |
Why?
|
Genetic Diseases, Inborn | 2 | 2013 | 588 | 0.360 |
Why?
|
Air Pollutants, Occupational | 6 | 2017 | 406 | 0.360 |
Why?
|
Knowledge Bases | 1 | 2009 | 85 | 0.350 |
Why?
|
Air Pollutants | 7 | 2021 | 2801 | 0.340 |
Why?
|
Acute Kidney Injury | 1 | 2022 | 1941 | 0.340 |
Why?
|
Adiponectin | 1 | 2015 | 1096 | 0.340 |
Why?
|
Vestibular Diseases | 1 | 2011 | 218 | 0.340 |
Why?
|
Epidemiologic Research Design | 2 | 2012 | 368 | 0.330 |
Why?
|
Artificial Intelligence | 3 | 2012 | 2124 | 0.330 |
Why?
|
Autistic Disorder | 1 | 2017 | 1164 | 0.320 |
Why?
|
Meta-Analysis as Topic | 1 | 2013 | 1339 | 0.320 |
Why?
|
Genetic Linkage | 7 | 2019 | 2433 | 0.320 |
Why?
|
Hematologic Diseases | 1 | 2011 | 496 | 0.310 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2022 | 2216 | 0.310 |
Why?
|
Chromosome Mapping | 7 | 2019 | 4743 | 0.310 |
Why?
|
Genomics | 7 | 2023 | 5652 | 0.300 |
Why?
|
Male | 98 | 2022 | 349022 | 0.300 |
Why?
|
Air Pollution | 6 | 2021 | 2268 | 0.300 |
Why?
|
Oligonucleotide Array Sequence Analysis | 8 | 2016 | 3922 | 0.300 |
Why?
|
Protein Interaction Mapping | 1 | 2011 | 626 | 0.300 |
Why?
|
Angiopoietin-2 | 2 | 2018 | 167 | 0.290 |
Why?
|
Statistics, Nonparametric | 5 | 2011 | 2881 | 0.290 |
Why?
|
Herpesvirus 4, Human | 2 | 2024 | 1038 | 0.280 |
Why?
|
Heart Rate | 6 | 2017 | 4095 | 0.280 |
Why?
|
Heart | 5 | 2017 | 4466 | 0.270 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2007 | 277 | 0.270 |
Why?
|
Manganese | 4 | 2017 | 407 | 0.270 |
Why?
|
Databases, Genetic | 2 | 2019 | 1777 | 0.270 |
Why?
|
Ovulation | 1 | 2006 | 190 | 0.260 |
Why?
|
Proteomics | 4 | 2023 | 3584 | 0.260 |
Why?
|
Blood Chemical Analysis | 1 | 2007 | 441 | 0.260 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 502 | 0.260 |
Why?
|
Pandemics | 7 | 2022 | 8274 | 0.260 |
Why?
|
Lung | 7 | 2023 | 9782 | 0.260 |
Why?
|
Acid Ceramidase | 3 | 2013 | 19 | 0.260 |
Why?
|
Gene Frequency | 9 | 2019 | 3585 | 0.250 |
Why?
|
Alcoholism | 1 | 2015 | 1892 | 0.250 |
Why?
|
Mercury | 2 | 2017 | 282 | 0.250 |
Why?
|
Female | 98 | 2022 | 378853 | 0.250 |
Why?
|
Abnormalities, Multiple | 1 | 2011 | 1405 | 0.240 |
Why?
|
Middle Aged | 71 | 2022 | 212863 | 0.230 |
Why?
|
Specimen Handling | 2 | 2010 | 692 | 0.230 |
Why?
|
Autonomic Nervous System | 3 | 2017 | 670 | 0.230 |
Why?
|
Cohort Studies | 21 | 2022 | 40389 | 0.230 |
Why?
|
Space-Time Clustering | 1 | 2003 | 51 | 0.230 |
Why?
|
Genes | 3 | 2013 | 1898 | 0.230 |
Why?
|
Gene Regulatory Networks | 5 | 2022 | 1706 | 0.230 |
Why?
|
Veterans | 3 | 2021 | 2505 | 0.220 |
Why?
|
Neoplasm Proteins | 3 | 2015 | 3694 | 0.220 |
Why?
|
Prostatic Neoplasms | 6 | 2014 | 10999 | 0.220 |
Why?
|
Patient Dropouts | 1 | 2005 | 419 | 0.220 |
Why?
|
Fetal Blood | 6 | 2019 | 1315 | 0.220 |
Why?
|
DNA Mutational Analysis | 1 | 2011 | 4182 | 0.220 |
Why?
|
Sleep Apnea Syndromes | 3 | 2021 | 932 | 0.220 |
Why?
|
Ferrochelatase | 2 | 2020 | 46 | 0.220 |
Why?
|
Blood Proteins | 1 | 2008 | 1122 | 0.220 |
Why?
|
Genetic Loci | 4 | 2020 | 2567 | 0.220 |
Why?
|
Bangladesh | 6 | 2018 | 677 | 0.210 |
Why?
|
Haplotypes | 7 | 2021 | 2782 | 0.210 |
Why?
|
Research | 2 | 2021 | 2001 | 0.210 |
Why?
|
Menopause | 3 | 2007 | 1613 | 0.210 |
Why?
|
Lead | 2 | 2017 | 851 | 0.210 |
Why?
|
Nails | 3 | 2014 | 289 | 0.210 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2018 | 1116 | 0.210 |
Why?
|
Sleep | 5 | 2019 | 4596 | 0.200 |
Why?
|
Mass Spectrometry | 2 | 2012 | 2200 | 0.200 |
Why?
|
Leukocytes | 4 | 2019 | 2035 | 0.200 |
Why?
|
Water Pollutants, Chemical | 3 | 2014 | 309 | 0.200 |
Why?
|
Age of Onset | 1 | 2008 | 3263 | 0.200 |
Why?
|
Aging, Premature | 1 | 2021 | 47 | 0.190 |
Why?
|
Epistasis, Genetic | 2 | 2015 | 365 | 0.190 |
Why?
|
Radiotherapy Dosage | 1 | 2007 | 2872 | 0.190 |
Why?
|
Twin Studies as Topic | 2 | 2018 | 105 | 0.190 |
Why?
|
Microfilament Proteins | 2 | 2017 | 1150 | 0.190 |
Why?
|
Maternal Exposure | 2 | 2017 | 952 | 0.180 |
Why?
|
Radiation Injuries | 1 | 2007 | 1161 | 0.180 |
Why?
|
Protoporphyria, Erythropoietic | 1 | 2020 | 43 | 0.180 |
Why?
|
Reproducibility of Results | 8 | 2022 | 19811 | 0.180 |
Why?
|
Esophageal Neoplasms | 4 | 2011 | 1575 | 0.180 |
Why?
|
Models, Biological | 6 | 2020 | 9609 | 0.180 |
Why?
|
Heme | 1 | 2022 | 306 | 0.180 |
Why?
|
Aged | 52 | 2022 | 162698 | 0.180 |
Why?
|
Interleukin-18 Receptor alpha Subunit | 1 | 2019 | 18 | 0.170 |
Why?
|
Chromosomes, Human, Pair 8 | 2 | 2019 | 463 | 0.170 |
Why?
|
5-Methylcytosine | 1 | 2020 | 153 | 0.170 |
Why?
|
Birth Weight | 3 | 2016 | 2062 | 0.170 |
Why?
|
Environmental Illness | 1 | 2019 | 34 | 0.170 |
Why?
|
Metabolic Networks and Pathways | 2 | 2022 | 781 | 0.170 |
Why?
|
Mortality | 2 | 2021 | 2851 | 0.170 |
Why?
|
Hexokinase | 1 | 2019 | 126 | 0.170 |
Why?
|
Heart Diseases | 6 | 2014 | 2782 | 0.170 |
Why?
|
Oncogenes | 3 | 2021 | 1264 | 0.160 |
Why?
|
Biological Transport | 1 | 2023 | 2118 | 0.160 |
Why?
|
Body Size | 1 | 2021 | 458 | 0.160 |
Why?
|
Humidity | 1 | 2019 | 193 | 0.160 |
Why?
|
Genes, Tumor Suppressor | 3 | 2019 | 1096 | 0.160 |
Why?
|
Adult | 51 | 2022 | 213394 | 0.160 |
Why?
|
Lymphocyte Count | 1 | 2020 | 791 | 0.160 |
Why?
|
Child Development Disorders, Pervasive | 2 | 2013 | 616 | 0.160 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2019 | 374 | 0.160 |
Why?
|
Prognosis | 9 | 2021 | 28901 | 0.150 |
Why?
|
Patient Compliance | 1 | 2008 | 2679 | 0.150 |
Why?
|
Adenocarcinoma | 5 | 2018 | 6318 | 0.150 |
Why?
|
Prenatal Exposure Delayed Effects | 4 | 2017 | 2393 | 0.150 |
Why?
|
Asymptomatic Diseases | 1 | 2020 | 549 | 0.150 |
Why?
|
Workflow | 1 | 2022 | 831 | 0.150 |
Why?
|
DNA-Binding Proteins | 5 | 2022 | 9622 | 0.150 |
Why?
|
Europe | 4 | 2020 | 3331 | 0.150 |
Why?
|
Receptors, Somatostatin | 2 | 2016 | 129 | 0.150 |
Why?
|
Michigan | 4 | 2012 | 349 | 0.150 |
Why?
|
Menarche | 2 | 2018 | 513 | 0.150 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2023 | 11699 | 0.140 |
Why?
|
Ohio | 2 | 2016 | 337 | 0.140 |
Why?
|
Environmental Monitoring | 5 | 2019 | 1408 | 0.140 |
Why?
|
Gene Dosage | 2 | 2011 | 1251 | 0.140 |
Why?
|
Neck | 1 | 2021 | 691 | 0.140 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2003 | 1127 | 0.140 |
Why?
|
Sulfates | 2 | 2014 | 386 | 0.140 |
Why?
|
Central America | 1 | 2016 | 68 | 0.140 |
Why?
|
Leukocyte Count | 1 | 2020 | 1581 | 0.140 |
Why?
|
Probability | 1 | 2022 | 2500 | 0.140 |
Why?
|
Dust | 3 | 2014 | 478 | 0.140 |
Why?
|
Phylogeography | 1 | 2016 | 82 | 0.140 |
Why?
|
Educational Status | 2 | 2023 | 2514 | 0.140 |
Why?
|
GTPase-Activating Proteins | 1 | 2019 | 498 | 0.140 |
Why?
|
Fasting | 1 | 2022 | 1587 | 0.140 |
Why?
|
Multifactorial Inheritance | 1 | 2023 | 1174 | 0.140 |
Why?
|
Bronchial Neoplasms | 1 | 2016 | 112 | 0.140 |
Why?
|
South America | 1 | 2016 | 181 | 0.140 |
Why?
|
Platelet Count | 2 | 2017 | 780 | 0.140 |
Why?
|
United States | 13 | 2022 | 69573 | 0.130 |
Why?
|
Histone Demethylases | 1 | 2018 | 311 | 0.130 |
Why?
|
Immunoglobulin E | 2 | 2019 | 1461 | 0.130 |
Why?
|
Genome, Viral | 1 | 2019 | 668 | 0.130 |
Why?
|
Fibrinogen | 1 | 2019 | 895 | 0.130 |
Why?
|
Renal Insufficiency | 1 | 2021 | 803 | 0.130 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2008 | 9812 | 0.130 |
Why?
|
Bone Density | 3 | 2007 | 3471 | 0.130 |
Why?
|
Maternal-Fetal Exchange | 1 | 2017 | 454 | 0.130 |
Why?
|
Risk Assessment | 8 | 2024 | 23294 | 0.130 |
Why?
|
Odds Ratio | 4 | 2018 | 9846 | 0.120 |
Why?
|
Cholesterol, LDL | 2 | 2022 | 2334 | 0.120 |
Why?
|
Sleep, REM | 1 | 2018 | 594 | 0.120 |
Why?
|
Skin Diseases | 2 | 2014 | 1065 | 0.120 |
Why?
|
Risk Factors | 21 | 2024 | 71974 | 0.120 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 2014 | 3504 | 0.120 |
Why?
|
Coronary Artery Disease | 4 | 2023 | 6416 | 0.120 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 628 | 0.120 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2017 | 485 | 0.120 |
Why?
|
Sensitivity and Specificity | 5 | 2015 | 14740 | 0.120 |
Why?
|
Intestinal Neoplasms | 1 | 2016 | 319 | 0.120 |
Why?
|
False Positive Reactions | 2 | 2017 | 982 | 0.120 |
Why?
|
Carbon | 2 | 2014 | 684 | 0.120 |
Why?
|
Asbestos | 1 | 2015 | 250 | 0.120 |
Why?
|
Time Factors | 12 | 2020 | 40050 | 0.110 |
Why?
|
Mutagens | 1 | 2014 | 168 | 0.110 |
Why?
|
Communicable Disease Control | 1 | 2020 | 853 | 0.110 |
Why?
|
Extracellular Matrix Proteins | 2 | 2019 | 847 | 0.110 |
Why?
|
Receptor, Notch2 | 1 | 2013 | 89 | 0.110 |
Why?
|
Nod2 Signaling Adaptor Protein | 1 | 2013 | 87 | 0.110 |
Why?
|
Health Education | 2 | 2014 | 1054 | 0.110 |
Why?
|
Inflammation | 3 | 2020 | 10534 | 0.110 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2015 | 430 | 0.110 |
Why?
|
Cognition | 4 | 2021 | 6686 | 0.110 |
Why?
|
Clinical Trials as Topic | 1 | 2009 | 7897 | 0.110 |
Why?
|
Analysis of Variance | 4 | 2017 | 6370 | 0.110 |
Why?
|
Forced Expiratory Volume | 5 | 2020 | 1740 | 0.110 |
Why?
|
Research Design | 3 | 2019 | 5959 | 0.110 |
Why?
|
Angiopoietins | 1 | 2012 | 80 | 0.110 |
Why?
|
Temperature | 1 | 2019 | 2202 | 0.110 |
Why?
|
C-Reactive Protein | 3 | 2019 | 3752 | 0.110 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2014 | 423 | 0.100 |
Why?
|
Plaque, Atherosclerotic | 1 | 2023 | 1483 | 0.100 |
Why?
|
Ribosomes | 1 | 2015 | 499 | 0.100 |
Why?
|
Food Hypersensitivity | 1 | 2019 | 613 | 0.100 |
Why?
|
Appendicitis | 1 | 2018 | 639 | 0.100 |
Why?
|
Longevity | 1 | 2019 | 1066 | 0.100 |
Why?
|
Signal Transduction | 7 | 2021 | 23355 | 0.100 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2012 | 287 | 0.100 |
Why?
|
Viral Proteins | 1 | 2019 | 1900 | 0.100 |
Why?
|
Interleukin-12 Subunit p35 | 1 | 2011 | 20 | 0.100 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2015 | 649 | 0.100 |
Why?
|
Quality Control | 2 | 2021 | 842 | 0.100 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 12049 | 0.100 |
Why?
|
Occupations | 1 | 2014 | 517 | 0.100 |
Why?
|
Nitrosamines | 1 | 2011 | 87 | 0.100 |
Why?
|
Environmental Pollutants | 2 | 2017 | 1172 | 0.100 |
Why?
|
Selection, Genetic | 1 | 2016 | 915 | 0.100 |
Why?
|
Heredity | 1 | 2011 | 153 | 0.100 |
Why?
|
Adiposity | 1 | 2021 | 1801 | 0.100 |
Why?
|
Aged, 80 and over | 19 | 2022 | 57650 | 0.100 |
Why?
|
Angiogenic Proteins | 1 | 2011 | 104 | 0.100 |
Why?
|
Inhalation Exposure | 1 | 2014 | 440 | 0.100 |
Why?
|
Rural Population | 1 | 2021 | 2181 | 0.100 |
Why?
|
Self Care | 2 | 2014 | 787 | 0.090 |
Why?
|
Heterozygote | 2 | 2021 | 2798 | 0.090 |
Why?
|
Risk | 3 | 2013 | 9684 | 0.090 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2011 | 167 | 0.090 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2015 | 683 | 0.090 |
Why?
|
Stress, Physiological | 2 | 2011 | 1405 | 0.090 |
Why?
|
Oxygen Consumption | 1 | 2016 | 1871 | 0.090 |
Why?
|
Disease Management | 3 | 2008 | 2448 | 0.090 |
Why?
|
Mutation | 6 | 2023 | 29658 | 0.090 |
Why?
|
Atherosclerosis | 2 | 2023 | 3401 | 0.090 |
Why?
|
China | 3 | 2020 | 2225 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 2277 | 0.090 |
Why?
|
Alleles | 5 | 2022 | 6942 | 0.090 |
Why?
|
Vital Capacity | 3 | 2020 | 922 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2014 | 1285 | 0.090 |
Why?
|
Estrogen Receptor beta | 1 | 2010 | 175 | 0.090 |
Why?
|
Elafin | 1 | 2009 | 33 | 0.090 |
Why?
|
Placenta | 1 | 2018 | 1682 | 0.090 |
Why?
|
Tumor Suppressor Proteins | 1 | 2019 | 2845 | 0.080 |
Why?
|
Child | 16 | 2020 | 77033 | 0.080 |
Why?
|
Occupational Diseases | 2 | 2014 | 1474 | 0.080 |
Why?
|
Particle Size | 4 | 2016 | 1639 | 0.080 |
Why?
|
Discriminant Analysis | 1 | 2009 | 235 | 0.080 |
Why?
|
Leukocyte Elastase | 1 | 2009 | 112 | 0.080 |
Why?
|
Lung Diseases | 1 | 2018 | 1879 | 0.080 |
Why?
|
Epithelial Cells | 1 | 2020 | 3671 | 0.080 |
Why?
|
Fetal Growth Retardation | 1 | 2012 | 570 | 0.080 |
Why?
|
Physicians, Primary Care | 1 | 2014 | 577 | 0.080 |
Why?
|
Hospitals | 1 | 2022 | 3916 | 0.080 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 3 | 2020 | 3029 | 0.080 |
Why?
|
Calcium-Binding Proteins | 1 | 2013 | 1078 | 0.080 |
Why?
|
Telomere | 1 | 2014 | 907 | 0.080 |
Why?
|
Receptors, Cell Surface | 1 | 2017 | 2864 | 0.080 |
Why?
|
Mutation, Missense | 1 | 2017 | 2552 | 0.080 |
Why?
|
Neutrophils | 1 | 2020 | 3698 | 0.080 |
Why?
|
Stress, Psychological | 2 | 2018 | 4212 | 0.080 |
Why?
|
Polysomnography | 4 | 2022 | 1765 | 0.080 |
Why?
|
Follicle Stimulating Hormone | 2 | 2007 | 739 | 0.080 |
Why?
|
Aging | 4 | 2021 | 8613 | 0.070 |
Why?
|
Menstrual Cycle | 3 | 2007 | 550 | 0.070 |
Why?
|
Sex Factors | 1 | 2021 | 10398 | 0.070 |
Why?
|
NF-kappa B | 2 | 2014 | 2502 | 0.070 |
Why?
|
Nuclear Proteins | 3 | 2023 | 5830 | 0.070 |
Why?
|
Parotid Gland | 1 | 2007 | 165 | 0.070 |
Why?
|
Body Mass Index | 5 | 2017 | 12655 | 0.070 |
Why?
|
Databases, Protein | 1 | 2009 | 382 | 0.070 |
Why?
|
Parity | 1 | 2010 | 930 | 0.070 |
Why?
|
Chromatography, Liquid | 1 | 2010 | 977 | 0.070 |
Why?
|
Gastroesophageal Reflux | 2 | 2011 | 782 | 0.070 |
Why?
|
Repressor Proteins | 1 | 2017 | 3007 | 0.070 |
Why?
|
Germ-Line Mutation | 1 | 2014 | 1786 | 0.070 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2014 | 2015 | 0.070 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2018 | 8400 | 0.070 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2007 | 877 | 0.070 |
Why?
|
Cytoskeletal Proteins | 1 | 2011 | 1369 | 0.070 |
Why?
|
Acceleration | 2 | 2017 | 181 | 0.070 |
Why?
|
Mexico | 2 | 2018 | 683 | 0.070 |
Why?
|
Adrenal Cortex Hormones | 2 | 2012 | 1833 | 0.070 |
Why?
|
Positron-Emission Tomography | 1 | 2022 | 6361 | 0.070 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2005 | 141 | 0.070 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2011 | 1157 | 0.070 |
Why?
|
Child Development | 1 | 2017 | 2213 | 0.070 |
Why?
|
Face | 1 | 2011 | 985 | 0.070 |
Why?
|
Prospective Studies | 12 | 2023 | 53037 | 0.070 |
Why?
|
Adolescent | 9 | 2022 | 85405 | 0.070 |
Why?
|
Phosphatidylethanolamine N-Methyltransferase | 2 | 2018 | 20 | 0.070 |
Why?
|
Patient Satisfaction | 2 | 2008 | 3382 | 0.070 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2005 | 134 | 0.070 |
Why?
|
Retrospective Studies | 7 | 2023 | 76631 | 0.060 |
Why?
|
Young Adult | 11 | 2022 | 56255 | 0.060 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 2 | 2019 | 186 | 0.060 |
Why?
|
Endoplasmic Reticulum | 1 | 2011 | 1141 | 0.060 |
Why?
|
Promoter Regions, Genetic | 2 | 2014 | 5863 | 0.060 |
Why?
|
Mendelian Randomization Analysis | 2 | 2022 | 950 | 0.060 |
Why?
|
Triglycerides | 1 | 2012 | 2447 | 0.060 |
Why?
|
Transcription Factors | 3 | 2023 | 12120 | 0.060 |
Why?
|
Apoptosis | 3 | 2010 | 9714 | 0.060 |
Why?
|
Sepsis | 1 | 2018 | 2571 | 0.060 |
Why?
|
Feedback | 1 | 2008 | 788 | 0.060 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2023 | 1674 | 0.060 |
Why?
|
Choice Behavior | 2 | 2008 | 801 | 0.060 |
Why?
|
Polymorphism, Genetic | 3 | 2014 | 4332 | 0.060 |
Why?
|
Pregnancy | 8 | 2018 | 29002 | 0.060 |
Why?
|
Tandem Mass Spectrometry | 1 | 2010 | 1156 | 0.060 |
Why?
|
Pharmacokinetics | 1 | 2004 | 88 | 0.060 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2013 | 2102 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 1 | 2016 | 4555 | 0.060 |
Why?
|
Metalloendopeptidases | 1 | 2005 | 395 | 0.060 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2394 | 0.060 |
Why?
|
Folic Acid | 1 | 2010 | 1297 | 0.060 |
Why?
|
Health Promotion | 2 | 2007 | 2187 | 0.060 |
Why?
|
Luteinizing Hormone | 1 | 2006 | 865 | 0.060 |
Why?
|
Massachusetts | 5 | 2014 | 8669 | 0.060 |
Why?
|
Information Storage and Retrieval | 1 | 2009 | 821 | 0.060 |
Why?
|
Respiratory Function Tests | 2 | 2020 | 1611 | 0.060 |
Why?
|
Saliva | 1 | 2007 | 805 | 0.060 |
Why?
|
Xerophthalmia | 1 | 2003 | 18 | 0.060 |
Why?
|
Epidemiologic Methods | 2 | 2009 | 1364 | 0.060 |
Why?
|
Multivariate Analysis | 3 | 2016 | 12237 | 0.060 |
Why?
|
HIV Protease Inhibitors | 1 | 2005 | 435 | 0.060 |
Why?
|
Indonesia | 1 | 2003 | 114 | 0.060 |
Why?
|
Common Cold | 1 | 2003 | 61 | 0.050 |
Why?
|
Lipid Metabolism | 1 | 2011 | 1891 | 0.050 |
Why?
|
Long Interspersed Nucleotide Elements | 2 | 2014 | 335 | 0.050 |
Why?
|
Down Syndrome | 1 | 2010 | 873 | 0.050 |
Why?
|
CD4 Lymphocyte Count | 2 | 2005 | 2602 | 0.050 |
Why?
|
Ozone | 1 | 2005 | 468 | 0.050 |
Why?
|
Menstruation Disturbances | 1 | 2003 | 148 | 0.050 |
Why?
|
Area Under Curve | 1 | 2006 | 1655 | 0.050 |
Why?
|
Epilepsy, Complex Partial | 1 | 2002 | 62 | 0.050 |
Why?
|
Interleukin-8 | 2 | 2016 | 685 | 0.050 |
Why?
|
Hematopoietic Stem Cells | 1 | 2014 | 3364 | 0.050 |
Why?
|
Blood Pressure | 1 | 2017 | 8554 | 0.050 |
Why?
|
Caveolin 1 | 1 | 2022 | 264 | 0.050 |
Why?
|
Research Subjects | 1 | 2003 | 237 | 0.050 |
Why?
|
Metals, Heavy | 2 | 2014 | 139 | 0.050 |
Why?
|
Maximal Midexpiratory Flow Rate | 1 | 2020 | 78 | 0.050 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2004 | 386 | 0.050 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2021 | 106 | 0.050 |
Why?
|
Membrane Proteins | 3 | 2014 | 7862 | 0.050 |
Why?
|
Follow-Up Studies | 5 | 2019 | 38942 | 0.050 |
Why?
|
Education, Medical, Continuing | 1 | 2006 | 840 | 0.050 |
Why?
|
Radiotherapy | 1 | 2007 | 1526 | 0.050 |
Why?
|
Population Density | 1 | 2021 | 194 | 0.050 |
Why?
|
Calcium | 2 | 2011 | 5742 | 0.050 |
Why?
|
Crohn Disease | 1 | 2013 | 2299 | 0.050 |
Why?
|
Genetic Testing | 1 | 2013 | 3441 | 0.050 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2023 | 364 | 0.050 |
Why?
|
Nasal Mucosa | 1 | 2003 | 372 | 0.050 |
Why?
|
Chromosomes | 1 | 2023 | 594 | 0.040 |
Why?
|
Homeostasis | 1 | 2011 | 3348 | 0.040 |
Why?
|
Breast Neoplasms | 6 | 2019 | 20676 | 0.040 |
Why?
|
Aneuploidy | 1 | 2023 | 533 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2021 | 278 | 0.040 |
Why?
|
Pyridines | 1 | 2011 | 2810 | 0.040 |
Why?
|
Interleukin-10 | 2 | 2016 | 1199 | 0.040 |
Why?
|
Stochastic Processes | 1 | 2020 | 346 | 0.040 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2015 | 4014 | 0.040 |
Why?
|
Gestational Age | 2 | 2019 | 3486 | 0.040 |
Why?
|
Parents | 3 | 2014 | 3368 | 0.040 |
Why?
|
Respiratory Tract Infections | 2 | 2005 | 956 | 0.040 |
Why?
|
Proteins | 1 | 2014 | 6082 | 0.040 |
Why?
|
Sulfur Dioxide | 1 | 2019 | 176 | 0.040 |
Why?
|
Uncertainty | 1 | 2024 | 721 | 0.040 |
Why?
|
Chromosomes, Human | 2 | 2016 | 456 | 0.040 |
Why?
|
Fetal Development | 2 | 2016 | 763 | 0.040 |
Why?
|
Electrocardiography | 3 | 2017 | 6426 | 0.040 |
Why?
|
Disease Susceptibility | 2 | 2020 | 1778 | 0.040 |
Why?
|
Pancreatic Neoplasms | 1 | 2016 | 5213 | 0.040 |
Why?
|
Introns | 1 | 2021 | 992 | 0.040 |
Why?
|
Minnesota | 2 | 2013 | 346 | 0.040 |
Why?
|
History, 21st Century | 2 | 2014 | 1534 | 0.040 |
Why?
|
Incidence | 4 | 2020 | 20913 | 0.040 |
Why?
|
Calcinosis | 1 | 2007 | 1493 | 0.040 |
Why?
|
Neoplasm Staging | 4 | 2018 | 10961 | 0.040 |
Why?
|
Placebos | 1 | 2003 | 1678 | 0.040 |
Why?
|
RNA-Binding Proteins | 2 | 2022 | 1890 | 0.040 |
Why?
|
DNA, Neoplasm | 2 | 2015 | 1754 | 0.040 |
Why?
|
Mothers | 2 | 2019 | 2143 | 0.040 |
Why?
|
Neuropsychological Tests | 1 | 2010 | 6963 | 0.040 |
Why?
|
Proteome | 1 | 2007 | 1772 | 0.040 |
Why?
|
Nerve Tissue Proteins | 2 | 2022 | 4463 | 0.040 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2018 | 137 | 0.040 |
Why?
|
Epilepsy | 2 | 2003 | 3289 | 0.040 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2019 | 265 | 0.040 |
Why?
|
DNA Helicases | 1 | 2023 | 843 | 0.040 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2012 | 2397 | 0.040 |
Why?
|
Disease Progression | 5 | 2017 | 13237 | 0.040 |
Why?
|
HIV Seropositivity | 1 | 2003 | 966 | 0.040 |
Why?
|
Psychotropic Drugs | 1 | 2003 | 891 | 0.040 |
Why?
|
Aryldialkylphosphatase | 1 | 2017 | 63 | 0.040 |
Why?
|
Chromium | 1 | 2017 | 123 | 0.040 |
Why?
|
Mutagenesis | 1 | 2021 | 1265 | 0.040 |
Why?
|
Chromosome Aberrations | 1 | 2023 | 1812 | 0.040 |
Why?
|
Nitrogen Dioxide | 1 | 2019 | 486 | 0.040 |
Why?
|
Oxygen | 2 | 2019 | 4158 | 0.030 |
Why?
|
Child, Preschool | 5 | 2018 | 40802 | 0.030 |
Why?
|
Obesity | 2 | 2011 | 12643 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2022 | 1424 | 0.030 |
Why?
|
Health Status | 3 | 2020 | 4013 | 0.030 |
Why?
|
Carbon Monoxide | 1 | 2019 | 526 | 0.030 |
Why?
|
Interleukin-1beta | 2 | 2014 | 970 | 0.030 |
Why?
|
Glucose | 2 | 2022 | 4377 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5632 | 0.030 |
Why?
|
Multicenter Studies as Topic | 2 | 2014 | 1583 | 0.030 |
Why?
|
Uric Acid | 1 | 2021 | 753 | 0.030 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2017 | 357 | 0.030 |
Why?
|
Liver | 1 | 2011 | 7449 | 0.030 |
Why?
|
Gases | 1 | 2016 | 192 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 3 | 2013 | 6516 | 0.030 |
Why?
|
Motor Skills | 1 | 2018 | 520 | 0.030 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2016 | 285 | 0.030 |
Why?
|
Interleukin-6 | 2 | 2016 | 3194 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2013 | 3510 | 0.030 |
Why?
|
Prevalence | 4 | 2019 | 15153 | 0.030 |
Why?
|
Endothelin-1 | 1 | 2016 | 313 | 0.030 |
Why?
|
Work | 1 | 2015 | 191 | 0.030 |
Why?
|
Somatostatin | 1 | 2016 | 460 | 0.030 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 554 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2016 | 6871 | 0.030 |
Why?
|
Labor Unions | 1 | 2014 | 47 | 0.030 |
Why?
|
Age Factors | 2 | 2008 | 18349 | 0.030 |
Why?
|
Smad Proteins | 1 | 2014 | 162 | 0.030 |
Why?
|
Heart Defects, Congenital | 1 | 2010 | 4546 | 0.030 |
Why?
|
Gene Expression | 2 | 2017 | 7788 | 0.030 |
Why?
|
Head and Neck Neoplasms | 1 | 2007 | 2706 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 2019 | 1070 | 0.030 |
Why?
|
Alu Elements | 1 | 2014 | 118 | 0.030 |
Why?
|
Air | 1 | 2014 | 182 | 0.030 |
Why?
|
Iron | 1 | 2022 | 1776 | 0.030 |
Why?
|
Chromogranin A | 1 | 2013 | 52 | 0.030 |
Why?
|
Sex Characteristics | 2 | 2018 | 2583 | 0.030 |
Why?
|
Diabetes Mellitus | 2 | 2009 | 5702 | 0.030 |
Why?
|
Malaria | 1 | 2003 | 1234 | 0.030 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2014 | 313 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2003 | 1907 | 0.030 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2015 | 584 | 0.030 |
Why?
|
Program Evaluation | 2 | 2014 | 2484 | 0.030 |
Why?
|
ras Proteins | 1 | 2018 | 1062 | 0.030 |
Why?
|
Up-Regulation | 1 | 2022 | 4205 | 0.030 |
Why?
|
Body Height | 1 | 2019 | 1577 | 0.030 |
Why?
|
Family Health | 1 | 2017 | 1281 | 0.030 |
Why?
|
11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2011 | 20 | 0.030 |
Why?
|
Spirometry | 1 | 2014 | 863 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2011 | 6174 | 0.030 |
Why?
|
Infant, Newborn | 3 | 2017 | 25470 | 0.020 |
Why?
|
Oligodendroglioma | 1 | 2013 | 279 | 0.020 |
Why?
|
Boston | 2 | 2015 | 9314 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2021 | 1777 | 0.020 |
Why?
|
Pediatrics | 1 | 2006 | 3454 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3508 | 0.020 |
Why?
|
DNA Transposable Elements | 1 | 2014 | 749 | 0.020 |
Why?
|
Phosphatidylethanolamines | 1 | 2011 | 138 | 0.020 |
Why?
|
Selection Bias | 1 | 2012 | 370 | 0.020 |
Why?
|
Patient Selection | 1 | 2003 | 4211 | 0.020 |
Why?
|
Severity of Illness Index | 3 | 2022 | 15511 | 0.020 |
Why?
|
Neoplasms | 1 | 2019 | 21507 | 0.020 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2011 | 127 | 0.020 |
Why?
|
Caspase 7 | 1 | 2010 | 56 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 2020 | 1779 | 0.020 |
Why?
|
Socioeconomic Factors | 3 | 2012 | 7726 | 0.020 |
Why?
|
Neural Stem Cells | 1 | 2017 | 843 | 0.020 |
Why?
|
Women's Health | 3 | 2005 | 2029 | 0.020 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2010 | 230 | 0.020 |
Why?
|
Sexual Behavior | 2 | 2011 | 2040 | 0.020 |
Why?
|
Caspase 9 | 1 | 2010 | 188 | 0.020 |
Why?
|
Spectrometry, X-Ray Emission | 1 | 2010 | 146 | 0.020 |
Why?
|
Respiration | 1 | 2016 | 1650 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2007 | 11460 | 0.020 |
Why?
|
Filtration | 1 | 2010 | 235 | 0.020 |
Why?
|
Individuality | 1 | 2011 | 303 | 0.020 |
Why?
|
Limit of Detection | 1 | 2010 | 264 | 0.020 |
Why?
|
Phosphatidylcholines | 1 | 2011 | 412 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2023 | 3051 | 0.020 |
Why?
|
Heart Septal Defects | 1 | 2010 | 192 | 0.020 |
Why?
|
Secretory Leukocyte Peptidase Inhibitor | 1 | 2009 | 23 | 0.020 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2017 | 1214 | 0.020 |
Why?
|
Sex Distribution | 1 | 2014 | 2296 | 0.020 |
Why?
|
Pregnancy Trimester, Second | 1 | 2012 | 732 | 0.020 |
Why?
|
Epidemiologic Studies | 1 | 2012 | 677 | 0.020 |
Why?
|
Oxidoreductases | 1 | 2011 | 424 | 0.020 |
Why?
|
Recurrence | 2 | 2013 | 8307 | 0.020 |
Why?
|
Primary Health Care | 1 | 2005 | 4537 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2016 | 1539 | 0.020 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2009 | 323 | 0.020 |
Why?
|
HIV Infections | 4 | 2013 | 16764 | 0.020 |
Why?
|
Norway | 1 | 2009 | 445 | 0.020 |
Why?
|
Pregnancy Trimester, First | 1 | 2012 | 847 | 0.020 |
Why?
|
Fas Ligand Protein | 1 | 2008 | 217 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2013 | 1793 | 0.020 |
Why?
|
Trans-Activators | 1 | 2018 | 2922 | 0.020 |
Why?
|
Erythrocytes | 1 | 2017 | 2453 | 0.020 |
Why?
|
Health Policy | 1 | 2020 | 2655 | 0.020 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2009 | 404 | 0.020 |
Why?
|
Insulin | 1 | 2022 | 6569 | 0.020 |
Why?
|
Thinness | 1 | 2011 | 475 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2010 | 976 | 0.020 |
Why?
|
Sexual Partners | 1 | 2011 | 727 | 0.020 |
Why?
|
Genes, p16 | 1 | 2007 | 157 | 0.020 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2009 | 470 | 0.020 |
Why?
|
Urination Disorders | 1 | 2008 | 240 | 0.020 |
Why?
|
Interleukin-2 | 1 | 2014 | 1883 | 0.020 |
Why?
|
Reference Standards | 1 | 2010 | 1018 | 0.020 |
Why?
|
Quality of Life | 1 | 2008 | 12640 | 0.020 |
Why?
|
Substance-Related Disorders | 1 | 2003 | 4239 | 0.020 |
Why?
|
Nicotine | 1 | 2011 | 670 | 0.020 |
Why?
|
Mass Screening | 1 | 2022 | 5265 | 0.020 |
Why?
|
Time | 1 | 2008 | 528 | 0.020 |
Why?
|
Matrix Metalloproteinase 12 | 1 | 2005 | 49 | 0.020 |
Why?
|
Risk-Taking | 1 | 2011 | 986 | 0.020 |
Why?
|
Creatinine | 1 | 2011 | 1903 | 0.020 |
Why?
|
Hospitalization | 1 | 2005 | 10208 | 0.020 |
Why?
|
Sexually Transmitted Diseases | 1 | 2011 | 616 | 0.020 |
Why?
|
Peak Expiratory Flow Rate | 1 | 2005 | 141 | 0.020 |
Why?
|
Genes, Neoplasm | 1 | 2007 | 375 | 0.020 |
Why?
|
Spouses | 1 | 2008 | 283 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2015 | 16646 | 0.020 |
Why?
|
Tobacco Smoke Pollution | 1 | 2011 | 814 | 0.020 |
Why?
|
Infant | 2 | 2017 | 34923 | 0.020 |
Why?
|
Body Weight | 2 | 2007 | 4660 | 0.020 |
Why?
|
Genes, p53 | 1 | 2007 | 752 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2021 | 4426 | 0.020 |
Why?
|
Body Weights and Measures | 1 | 2005 | 209 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2011 | 2711 | 0.020 |
Why?
|
Mandelic Acids | 1 | 2004 | 47 | 0.020 |
Why?
|
Genes, ras | 1 | 2007 | 693 | 0.020 |
Why?
|
Cadherins | 1 | 2009 | 901 | 0.020 |
Why?
|
Comorbidity | 2 | 2010 | 10362 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2007 | 607 | 0.010 |
Why?
|
Waist-Hip Ratio | 1 | 2005 | 517 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2011 | 2131 | 0.010 |
Why?
|
Fatty Acids | 1 | 2011 | 1804 | 0.010 |
Why?
|
Intestinal Diseases | 1 | 2008 | 531 | 0.010 |
Why?
|
Leptin | 1 | 2011 | 1589 | 0.010 |
Why?
|
Affect | 1 | 2010 | 1475 | 0.010 |
Why?
|
Zidovudine | 1 | 2004 | 623 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2014 | 3087 | 0.010 |
Why?
|
Base Sequence | 1 | 2014 | 12804 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2015 | 4454 | 0.010 |
Why?
|
Anthropometry | 1 | 2007 | 1344 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 11410 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2014 | 4400 | 0.010 |
Why?
|
Hyperlipidemias | 1 | 2007 | 785 | 0.010 |
Why?
|
Femur Neck | 1 | 2004 | 309 | 0.010 |
Why?
|
HIV Seronegativity | 1 | 2003 | 209 | 0.010 |
Why?
|
Critical Illness | 1 | 2015 | 2656 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 3 | 2013 | 20055 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2013 | 4560 | 0.010 |
Why?
|
Nuclear Family | 1 | 2002 | 318 | 0.010 |
Why?
|
Narcotics | 1 | 2003 | 343 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 18125 | 0.010 |
Why?
|
Methadone | 1 | 2003 | 307 | 0.010 |
Why?
|
Anti-Asthmatic Agents | 1 | 2005 | 533 | 0.010 |
Why?
|
Walking | 1 | 2007 | 1177 | 0.010 |
Why?
|
Schizophrenia | 1 | 2019 | 6866 | 0.010 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2003 | 270 | 0.010 |
Why?
|
Attention | 1 | 2010 | 2400 | 0.010 |
Why?
|
Brachytherapy | 1 | 2008 | 1247 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2013 | 11347 | 0.010 |
Why?
|
Premenopause | 1 | 2004 | 1028 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2008 | 3453 | 0.010 |
Why?
|
Androgen Antagonists | 1 | 2008 | 1343 | 0.010 |
Why?
|
Prostatectomy | 1 | 2008 | 1858 | 0.010 |
Why?
|
Chronic Disease | 1 | 2014 | 9133 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2009 | 2901 | 0.010 |
Why?
|
Treatment Outcome | 4 | 2008 | 62693 | 0.010 |
Why?
|
Substance Abuse, Intravenous | 1 | 2003 | 523 | 0.010 |
Why?
|
Environment | 1 | 2004 | 1110 | 0.010 |
Why?
|
Prostate-Specific Antigen | 1 | 2008 | 2441 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 24714 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 7690 | 0.010 |
Why?
|
Survivors | 1 | 2008 | 2280 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2008 | 2639 | 0.010 |
Why?
|
Urban Population | 1 | 2005 | 2014 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2007 | 4832 | 0.010 |
Why?
|
Social Support | 1 | 2006 | 2112 | 0.010 |
Why?
|
ROC Curve | 1 | 2003 | 3526 | 0.010 |
Why?
|
Data Collection | 1 | 2005 | 3341 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2013 | 9122 | 0.010 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2003 | 1896 | 0.010 |
Why?
|
Lumbar Vertebrae | 1 | 2004 | 1843 | 0.010 |
Why?
|
Uterine Neoplasms | 1 | 2004 | 1511 | 0.010 |
Why?
|
Mental Health | 1 | 2007 | 2946 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2009 | 15036 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2011 | 21863 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2005 | 3609 | 0.010 |
Why?
|
Mice | 2 | 2011 | 81002 | 0.010 |
Why?
|
Medicaid | 1 | 2005 | 2711 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2013 | 11668 | 0.010 |
Why?
|
Registries | 1 | 2005 | 8039 | 0.010 |
Why?
|
Anti-HIV Agents | 1 | 2004 | 4320 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2007 | 18003 | 0.010 |
Why?
|
Animals | 2 | 2011 | 168368 | 0.000 |
Why?
|
Hypertension | 1 | 2007 | 8431 | 0.000 |
Why?
|
Ovarian Neoplasms | 1 | 2004 | 4815 | 0.000 |
Why?
|
Electroencephalography | 1 | 2002 | 6133 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2008 | 15194 | 0.000 |
Why?
|